Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, March 2007, p. 1123-1125, Vol. 51, No. 3
0066-4804/07/$08.00+0 doi:10.1128/AAC.01187-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Gierczy
ski
Department of Bacteriology, National Institute of Hygiene, Warsaw, Poland
Received 22 September 2006/ Returned for modification 12 November 2006/ Accepted 19 December 2006
We tested 102 Campylobacter jejuni and 6 Campylobacter coli clinical isolates from Poland. All were susceptible to erythromycin. Among the tested C. jejuni isolates 55.9% and 13.7% were resistant to ciprofloxacin and tetracycline, respectively. Replacement of Thr86 with Ile in GyrA and a plasmid-borne tet(O) gene were the main resistance mechanisms for fluoroquinolones and tetracycline, respectively.
Published ahead of print on 8 January 2007.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»